UNH

521.66

-0.57%↓

NVO

132.23

+0.27%↑

JNJ

151.63

-1.99%↓

ABBV

164.87

-0.93%↓

MRK

131.05

-0.12%↓

UNH

521.66

-0.57%↓

NVO

132.23

+0.27%↑

JNJ

151.63

-1.99%↓

ABBV

164.87

-0.93%↓

MRK

131.05

-0.12%↓

UNH

521.66

-0.57%↓

NVO

132.23

+0.27%↑

JNJ

151.63

-1.99%↓

ABBV

164.87

-0.93%↓

MRK

131.05

-0.12%↓

UNH

521.66

-0.57%↓

NVO

132.23

+0.27%↑

JNJ

151.63

-1.99%↓

ABBV

164.87

-0.93%↓

MRK

131.05

-0.12%↓

UNH

521.66

-0.57%↓

NVO

132.23

+0.27%↑

JNJ

151.63

-1.99%↓

ABBV

164.87

-0.93%↓

MRK

131.05

-0.12%↓

Home・Stock List・Eli Lilly and Co.

Eli Lilly and Co.

Closed

Sector Healthcare

775.06 0.67

Buy Sell

Overview

Share price change

24h

Current

Min

767.14

Max

778.73

Key metrics
By Trading Economics
Income	2.2B 2.2B
Sales	-583M 8.8B
P/E Sector Avg	105.456 23.904
EPS	2.58
Dividend yield	0.964
Profit margin	23.41
Employees	43,000
EBITDA	3.8B

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+14.42 upside

Dividends
By Dow Jones
Dividend yield Sector Avg	0.96% 7.76%
Next Earnings	8 Aug 2024
Next Dividend date	10 Jun 2024
Next Ex Dividend date	12 Aug 2024

Market Stats
By TradingEconomics
Market Cap	1.4B 738B
Previous open	774.39
Previous close	775.06

News Sentiment

By Acuity

92%

350 / 368 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

762.11 / 787.02 Support & Resistance

Eli Lilly and Co. Chart

Related News

9 May 2024, 12:00 UTC

Top News

Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled -- WSJ

3 May 2024, 21:33 UTC

Earnings

Amazon Stock Is on a Roll. Here's Why It's on This Firm's 'Best Ideas List.' -- Barrons.com

30 Apr 2024, 20:21 UTC

Earnings

These Stocks Moved the Most Today: MicroStrategy, Eli Lilly, 3M, PayPal, GE Healthcare, F5, Tesla, Chegg, Super Micro, and More -- Barrons.com

30 Apr 2024, 18:24 UTC

Earnings

These Stocks Are Moving the Most Today: MicroStrategy, Eli Lilly, 3M, PayPal, GE Healthcare, F5, Tesla, Chegg, Super Micro, and More -- Barrons.com

30 Apr 2024, 13:55 UTC

Hot Stocks

Stocks to Watch Tuesday: PayPal, Eli Lilly, 3M, McDonald's -- WSJ

30 Apr 2024, 13:19 UTC

Earnings

Eli Lilly Stock Jumps After Earnings Beat. Weight-Loss Drugs Are Driving Gains. -- Barrons.com

30 Apr 2024, 11:44 UTC

Earnings

Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound Sales Easily Beat -- IBD

30 Apr 2024, 11:08 UTC

Earnings

Eli Lilly Stock Jumps After Earnings Beat. Weight-Loss Drugs Are Driving Gains. -- Barrons.com

30 Apr 2024, 11:02 UTC

Earnings

Eli Lilly's Stock Jumps As First-Quarter Profit Tops Estimates Amid Strong Sales Of Mounjaro, Zepbound -- MarketWatch

30 Apr 2024, 10:47 UTC

Earnings

Eli Lilly Sees 2024 EPS $13.05-EPS $13.55 >LLY

30 Apr 2024, 10:47 UTC

Earnings

Eli Lilly Sees 2024 Adj EPS $13.50-Adj EPS $14.00 >LLY

30 Apr 2024, 10:46 UTC

Earnings

Eli Lilly: Raised Revenue View Reflects Strong Performance of Mounjaro, Zepbound, Greater Visibility Into Production Expansion >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly Raises Full-Year Revenue Guidance by $2 Billion >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Humalog Rev $538.7M >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Jardiance Rev $686.5M >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Trulicity Rev $1.46B >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Adj EPS $2.58 >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q EPS $2.48 >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Net $2.24B >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly Sees FY Rev $42.4B-$43.6B >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Rev $8.77B >LLY

30 Apr 2024, 09:14 UTC

Hot Stocks

Stocks to Watch Tuesday: Stellantis, HSBC, Coca-Cola -- WSJ

26 Apr 2024, 20:09 UTC

Earnings

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed -- IBD

25 Apr 2024, 12:31 UTC

Acquisitions, Mergers, Takeovers

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market -- IBD

4 Apr 2024, 05:00 UTC

Top News

Big Pharma Stocks Need a Rethink. Investors Keep -2-

4 Apr 2024, 05:00 UTC

Top News

Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake. -- Barrons.com

2 Apr 2024, 12:51 UTC

Earnings

Eli Lilly's Ozempic Competitors Face Risks. Why the Stock Has More Upside. -- Barrons.com

23 Mar 2024, 13:00 UTC

Top News

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

21 Mar 2024, 14:59 UTC

Top News

Medicare Opens Door for Covering Obesity Drugs -- Update

19 Mar 2024, 20:03 UTC

Acquisitions, Mergers, Takeovers

Fusion Rockets 97%, As Radiopharmaceuticals Space Sparks On $2 Billion AstraZeneca Takeover -- IBD

Peer Comparison

Price change

Eli Lilly and Co. Forecast

Price Target

By TipRanks

14.42% upside

12 Months Forecast

Average 881 USD 14.42%

High 1,001 USD

Low 740 USD

Based on 20 Wall Street analysts offering 12 month price targets forEli Lilly and Co. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

20 ratings

Buy

Hold

Sell

Based on 20 analysts giving stock ratings to Eli Lilly and Co. - Dist in the past 3 months.

Technical Score

By Trading Central

762.11 / 787.02Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There are no events.

Sentiment

By Acuity

350 / 368 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Eli Lilly and Co.

Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.